Supernus Pharmaceuticals, Inc.

SUPNNASDAQ Global Market·USD·Closed

SUPNNASDAQ·USD·Closed

$44.63

−2.15%

$44.63

−$0.98 (2.15%)

52W Range

40thpctl

Volume

0.75×avg

Mkt Cap

2.59BUSD

P/E

-87.3TTM

Div Yield

–ann

Healthcare · Drug Manufacturers - Specialty & Generic

52W Range

40thpctl

Volume

0.75×avg

Market Cap

2.59BUSD

P/E Ratio

-87.3TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+8.9% / yr

Operating margin-5.4%

ROIC-2.2%

Financially safe

Stretched

Debt / equity0.04×

Interest coverage0.0×

Current ratio1.96×